Four-Color Flow Cytometry Shows Strong Concordance With Bone Marrow Morphology and Cytogenetics in the Evaluation for Myelodysplasia
Authors:
- Jonathan R. FrommJFJonathan R. Fromm
- Anthony RossiniARAnthony Rossini
- Ying LiYLYing Li
- Anthony ChangACAnthony Chang
- Thomas H. NorwoodTNThomas H. Norwood
- Brent L.WoodBLBrent L.Wood
- 1 August 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 124 (2) , 170-181
Abstract
The ability of 4-color flow cytometry (FC) to help identify myelodysplastic syndromes (MDSs) was evaluated in 124 bone marrow aspirates from unselected patients with unexplained cytopenias and/or monocytosis. The morphologic features of bone marrow aspirate smears were correlated with FC and cytogenetic findings blindly, and patterns of antigen expression were compared with patterns seen in nonneoplastic and normal marrow specimens. Of 124 cases, 58 (46.7%) had definitive FC abnormalities ("flow-abnormal"), 19 cases (15.3%) had mild FC abnormalities of indeterminate significance, and 47 cases (37.9%) had essentially normal FC. Highly significant differences were identified between the flow-abnormal group and other groups in mean myeloid blast percentages and numbers of abnormal antigens expressed, even when the analysis was limited to cases with fewer than 5% myeloid blasts. Strikingly, flow-abnormal cases constituted 50 (89%) of the 56 morphologically abnormal cases and 31 (94%) of the 33 cytogenetically abnormal cases, demonstrating the strong concordance of FC-identified antigenic abnormalities with morphologic features and cytogenetics in the evaluation of patients with unexplained cytopenias.Keywords
This publication has 20 references indexed in Scilit:
- Peripheral blood MDS score: A new flow cytometric tool for the diagnosis of myelodysplastic syndromesCytometry Part B: Clinical Cytometry, 2005
- Evidence for expression of early myeloid antigens in mature, non-blast myeloid cells in myelodysplasiaAmerican Journal of Hematology, 2003
- Expression and prognostic significance of Bcl‐2 family proteins in myelodysplastic syndromesAmerican Journal of Hematology, 2002
- Decreased amount of mpl and reduced expression of glycoprotein IIb/IIIa and glycoprotein Ib on platelets from patients with refractory anemia: analysis by a non-isotopic quantitative ligand binding assay and immunofluorescenceEuropean Journal of Haematology, 2001
- Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspasesBritish Journal of Haematology, 2001
- Apoptotic index by Annexin V flow cytometry: Adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromesCytometry, 2001
- Expression and activity of caspases 1 and 3 in myelodysplastic syndromesLeukemia, 2000
- Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemiaLeukemia Research, 2000
- Altered surface expression of effector cell molecules on neutrophils in myelodysplastic syndromesBritish Journal of Haematology, 1997
- Neural Cell Adhesion Molecule (CD56)–Positive Acute Myelogenous Leukemia and Myelodysplastic and Myeloproliferative SyndromesAmerican Journal of Clinical Pathology, 1997